TRAIL agonists rescue mice from radiation-induced lung injury
Preprint
Abstract
Cancer therapy is often limited by toxicity from pneumonitis. This often-lethal side effect is known to be impacted by innate immunity, and in particular the pathways regulated by the TRAIL death receptor DR5. We investigated whether DR5 agonists could rescue mice from the lethal effects of radiation. We found that two different agonists, parenteral PEGylated trimeric-TRAIL (TLY012) and oral TRAIL-Inducing Compound #10 (TIC10/ONC201), could achieve this goal. Both compounds could completely protect mice from lethality by reducing pneumonitis, alveolar-wall thickness, and oxygen desaturation. At the molecular level, this protection appeared to be due to the inhibition of CCl22, a macrophage-derived chemokine previously associated with radiation pneumonitis and pulmonary fibrosis. The discovery that short-term treatment with TRAIL pathway agonists effectively rescues animals from high doses of radiation exposure has important translational implications. One Sentence Summary: Prevention of lethality, pneumonitis, lung fibrosis and skin dermatitis post-ψ-irradiation by short- term treatment with innate immune TRAIL pathway agonistsKeywords
This publication has 41 references indexed in Scilit:
- NKG2D ligands mediate immunosurveillance of senescent cellsAging, 2016
- HERC6 Is the Main E3 Ligase for Global ISG15 Conjugation in Mouse CellsPLOS ONE, 2012
- COX-2's new role in inflammationNature Chemical Biology, 2010
- Prediction of Radiation Pneumonitis Following High-dose Thoracic Radiation Therapy by 3 Gy/fraction for Non-small Cell Lung Cancer: Analysis of Clinical and Dosimetric FactorsJapanese Journal of Clinical Oncology, 2009
- TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesisJournal of Clinical Investigation, 2008
- Bortezomib Mediates Antiangiogenesis in Multiple Myeloma via Direct and Indirect Effects on Endothelial CellsCancer Research, 2006
- DR5 Knockout Mice Are Compromised in Radiation-Induced ApoptosisMolecular and Cellular Biology, 2005
- Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding siteOncogene, 2000
- KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor geneNature Genetics, 1997
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993